TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Executive Pay 2024

TEVA PHARMACEUTICAL INDUSTRIES LTD's top 5 named executive officers received combined total compensation of $38.1 million in fiscal year 2024.

The named executive officers disclosed in TEVA PHARMACEUTICAL INDUSTRIES LTD's 2024 proxy statement are:Richard Francis (President and Chief Executive Officer) with total compensation of $15.5 million, Eli Kalif (Executive Vice President Chief Financial Officer) with total compensation of $6.2 million, Dr. Eric Hughes (Executive Vice President Global R&D and Chief Medical Officer) with total compensation of $5.8 million, Richard Daniell (Executive Vice President European Commercial) with total compensation of $5.4 million, and Christine Fox (Executive Vice President US Commercial) with total compensation of $5.2 million.